Immune therapy for breast cancer in 2010-hype or hope?
- PMID: 21331271
- PMCID: PMC3031364
- DOI: 10.3747/co.v18i1.623
Immune therapy for breast cancer in 2010-hype or hope?
Abstract
The identification of numerous breast cancer antigens has generated increasing enthusiasm for the application of immune-based therapies in breast malignancies. Although the use of monoclonal antibodies has revolutionized the "targeted therapy" of breast cancer, and the immunomodulatory effects of bisphosphonates continue to be evaluated, few studies to date have demonstrated widespread utility for other forms of immunotherapy. The present review assesses modern research and explores whether the hopes for immunotherapy can overcome the hype.
Keywords: Breast cancer; cancer vaccine; cytokine; immunotherapy; monoclonal antibody.
References
-
- Stewart TH. Evidence for immune facilitation of breast cancer growth and for the immune promotion of oncogenesis in breast cancer. Medicina (B Aires) 1996;56(suppl 1):13–24. - PubMed
-
- Ding L, Lalani EN, Reddish M, et al. Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human muc1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human muc1 gene. Cancer Immunol Immunother. 1993;36:9–17. doi: 10.1007/BF01789125. - DOI - PMC - PubMed
-
- Acres RB, Hareuveni M, Balloul JM, Kieny MP. Vaccinia virus muc1 immunization of mice: immune response and protection against the growth of murine tumors bearing the muc1 antigen. J Immunother Emphasis Tumor Immunol. 1993;14:136–43. - PubMed
-
- Apostolopoulos V, Xing PX, McKenzie IF. Murine immune response to cells transfected with human muc1: immunization with cellular and synthetic antigens. Cancer Res. 1994;54:5186–93. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
